Thomas W Ferguson1,2, Amit X Garg3,4,5, Manish M Sood6, Claudio Rigatto1,2, Elaine Chau1,2, Paul Komenda1,2, David Naimark7, Gihad E Nesrallah5,8, Steven D Soroka9,10, Monica Beaulieu11,12, Ahsan Alam13, S Joseph Kim7, Stephanie Dixon3,5, Braden Manns14, Navdeep Tangri1,2. 1. Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. 2. Seven Oaks General Hospital, Chronic Disease Innovation Centre, Winnipeg, Manitoba, Canada. 3. Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada. 4. Department of Medicine, Western University, London, Ontario, Canada. 5. Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. 6. The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. 7. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. 8. Humber River Hospital, Toronto, Ontario, Canada. 9. Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada. 10. Nova Scotia Health Authority, Halifax, Nova Scotia, Canada. 11. Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. 12. BC Renal Agency, Vancouver, British Columbia, Canada. 13. Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada. 14. O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada.
Abstract
Importance: Published in 2010, the Initiating Dialysis Early and Late (IDEAL) randomized clinical trial, which randomized patients with an estimated glomerular filtration rate (GFR) between 10 and 15 mL/min/1.73 m2 to planned initiation of dialysis with an estimated GFR between 10 and 14 mL/min/1.73 m2 (early start) or an estimated GFR between 5 and 7 mL/min/1.73 m2 (late start), concluded that early initiation was not associated with improved survival or clinical outcomes. Objective: To assess the association between the IDEAL trial results and the proportion of early dialysis starts over time. Design, Setting, and Participants: This interrupted time series analysis used data from the Canadian Organ Replacement Register to study adult (≥18 years of age) patients with incident chronic dialysis between January 1, 2006, and December 31, 2015, in Canada, which has a universal health care system. Patients from the province of Quebec were excluded because its privacy laws preclude submission of deidentified data without first-person consent. The patients included in the study (n = 28 468) had at least 90 days of nephrologist care before starting dialysis and a recorded estimated GFR at dialysis initiation. Data analyses were performed from November 2016 to January 2019. Main Outcomes and Measures: The primary outcome was the proportion of early dialysis starts (estimated GFR >10.5 mL/min/1.73 m2), and the secondary outcomes included the proportions of acute inpatient dialysis starts, patients who started dialysis using a home modality, and patients receiving hemodialysis who started with an arteriovenous access. Measures included the trend prior to the IDEAL trial publication, the change in this trend after publication, and the immediate consequence of publication. Results: The final cohort comprised 28 468 patients, of whom 17 342 (60.9%) were male and the mean (SD) age was 64.8 (14.6) years. Before the IDEAL trial, a statistically significant increasing trend was observed in the monthly proportion of early dialysis starts (adjusted rate ratio, 1.002; 95% CI, 1.001-1.004; P = .004). After the IDEAL trial, an immediate decrease was observed in the proportion of early dialysis starts (rate ratio, 0.874; 95% CI, 0.818-0.933; P < .001), along with a statistically significant change in trend between the pretrial and posttrial periods (rate ratio, 0.994; 95% CI, 0.992-0.996; P < .001). No statistically significant differences were found in acute inpatient dialysis initiations, the proportion of patients receiving home dialysis as the initial modality, or the proportion of arteriovenous access creation at hemodialysis initiation after the IDEAL trial publication. Conclusions and Relevance: The publication of the IDEAL trial appeared to be associated with an immediate and meaningful change in the timing of dialysis initiation in Canada.
RCT Entities:
Importance: Published in 2010, the Initiating Dialysis Early and Late (IDEAL) randomized clinical trial, which randomized patients with an estimated glomerular filtration rate (GFR) between 10 and 15 mL/min/1.73 m2 to planned initiation of dialysis with an estimated GFR between 10 and 14 mL/min/1.73 m2 (early start) or an estimated GFR between 5 and 7 mL/min/1.73 m2 (late start), concluded that early initiation was not associated with improved survival or clinical outcomes. Objective: To assess the association between the IDEAL trial results and the proportion of early dialysis starts over time. Design, Setting, and Participants: This interrupted time series analysis used data from the Canadian Organ Replacement Register to study adult (≥18 years of age) patients with incident chronic dialysis between January 1, 2006, and December 31, 2015, in Canada, which has a universal health care system. Patients from the province of Quebec were excluded because its privacy laws preclude submission of deidentified data without first-person consent. The patients included in the study (n = 28 468) had at least 90 days of nephrologist care before starting dialysis and a recorded estimated GFR at dialysis initiation. Data analyses were performed from November 2016 to January 2019. Main Outcomes and Measures: The primary outcome was the proportion of early dialysis starts (estimated GFR >10.5 mL/min/1.73 m2), and the secondary outcomes included the proportions of acute inpatient dialysis starts, patients who started dialysis using a home modality, and patients receiving hemodialysis who started with an arteriovenous access. Measures included the trend prior to the IDEAL trial publication, the change in this trend after publication, and the immediate consequence of publication. Results: The final cohort comprised 28 468 patients, of whom 17 342 (60.9%) were male and the mean (SD) age was 64.8 (14.6) years. Before the IDEAL trial, a statistically significant increasing trend was observed in the monthly proportion of early dialysis starts (adjusted rate ratio, 1.002; 95% CI, 1.001-1.004; P = .004). After the IDEAL trial, an immediate decrease was observed in the proportion of early dialysis starts (rate ratio, 0.874; 95% CI, 0.818-0.933; P < .001), along with a statistically significant change in trend between the pretrial and posttrial periods (rate ratio, 0.994; 95% CI, 0.992-0.996; P < .001). No statistically significant differences were found in acute inpatient dialysis initiations, the proportion of patients receiving home dialysis as the initial modality, or the proportion of arteriovenous access creation at hemodialysis initiation after the IDEAL trial publication. Conclusions and Relevance: The publication of the IDEAL trial appeared to be associated with an immediate and meaningful change in the timing of dialysis initiation in Canada.
Authors: Gihad E Nesrallah; Reem A Mustafa; William F Clark; Adam Bass; Lianne Barnieh; Brenda R Hemmelgarn; Scott Klarenbach; Robert R Quinn; Swapnil Hiremath; Pietro Ravani; Manish M Sood; Louise M Moist Journal: CMAJ Date: 2014-02-04 Impact factor: 8.262
Authors: Anthony Harris; Bruce A Cooper; Jing Jing Li; Liliana Bulfone; Pauline Branley; John F Collins; Jonathan C Craig; Margaret B Fraenkel; David W Johnson; Joan Kesselhut; Grant Luxton; Andrew Pilmore; Martin Rosevear; David J Tiller; Carol A Pollock; David C Harris Journal: Am J Kidney Dis Date: 2011-02-23 Impact factor: 8.860
Authors: Bruce A Cooper; Pauline Branley; Liliana Bulfone; John F Collins; Jonathan C Craig; Margaret B Fraenkel; Anthony Harris; David W Johnson; Joan Kesselhut; Jing Jing Li; Grant Luxton; Andrew Pilmore; David J Tiller; David C Harris; Carol A Pollock Journal: N Engl J Med Date: 2010-06-27 Impact factor: 91.245
Authors: Irina Gorodetskaya; Stefanos Zenios; Charles E McCulloch; Alan Bostrom; Chi-Yuan Hsu; Andrew B Bindman; Alan S Go; Glenn M Chertow Journal: Kidney Int Date: 2005-12 Impact factor: 10.612
Authors: Elaine Ku; Raymond K Hsu; Kirsten L Johansen; Charles E McCulloch; Mark Mitsnefes; Barbara A Grimes; Kathleen D Liu Journal: PLoS Med Date: 2021-02-19 Impact factor: 11.069
Authors: Navdeep Tangri; Amit X Garg; Thomas W Ferguson; Stephanie Dixon; Claudio Rigatto; Selina Allu; Elaine Chau; Paul Komenda; David Naimark; Gihad E Nesrallah; Steven D Soroka; Monica Beaulieu; Ahsan Alam; S Joseph Kim; Manish M Sood; Braden Manns Journal: J Am Soc Nephrol Date: 2021-04-15 Impact factor: 14.978
Authors: Chi-Yuan Hsu; Rishi V Parikh; Leonid N Pravoverov; Sijie Zheng; David V Glidden; Thida C Tan; Alan S Go Journal: JAMA Intern Med Date: 2020-12-01 Impact factor: 21.873
Authors: Thomas W Ferguson; Drew Hager; Reid H Whitlock; Michelle Di Nella; Navdeep Tangri; Paul Komenda; Claudio Rigatto Journal: Kidney Int Rep Date: 2020-03-18